Latest filing published 06 Jun 2025 for Stoke Therapeutics, Inc., €26.8M.
Filing timeline
BuySaleInsider track record
Skorpios Trust: trading record in brief
Skorpios Trust discloses dealings in 2 companies, chiefly Stoke Therapeutics, Inc. and Akero Therapeutics, Inc. In total, 5 filings cover trades dated from 1 December 2022 to 4 June 2025.
Every open-market trade on record is a sale: 5 sales worth €180.6M. So far in 2025, the count stands at no purchases and 1 sale.
The record was last updated on 6 June 2025 with an open-market sale (€26.8M) in Stoke Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Skorpios Trust
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000,000 shares@ US$10.2023.8% of flowCommon StockSEC:0001062993-25-011153:0
- 2,000,000 shares@ US$11.5019.6% of flowCommon StockSEC:0001062993-24-021228:0
- 1,937,500 shares@ US$14.0521.7% of flowCommon StockSEC:0001062993-24-016894:0
- 3,600,000 shares@ US$11.6034.8% of flowCommon StockSEC:0001062993-24-008547:0
- 1,636,000 shares@ US$43.50100.0% of flowCommon StockSEC:0001062993-22-023333:0
5 of 5 declarations
